| PI | Title | Source | Year |
Total Funding |
Abstract |
| Rabeneck |
Team in Population-Based Colorectal Cancer Screening |
CIHR | 2007-2012 | $2.4Million | |
| McGregor | Engaging family physicians in an intervention to increase uptake of colorectal cancer screening | ACB | 2007-2010 |
$456,309 | |
| Hilsden | Evaluation of a novel serum-marker of colorectal cancer |
PDI | 2008-2010 | $100,000 | |
| Rabeneck | Risk of Advanced Proximal Neoplasia |
CIHR | |||
| Rostom | A randomized prospective trial comparing oral sodium phosphate, polyethylene glycol-based lavage (Golytely) and split dose polyethylene glycol-based lavage in the preparation of patients undergoing colonoscopy. | Internal | |||
| Rostom | A randomized prospective trial comparing magnesium citrate (Pico-Salax) alone, Pico-Salax plus bisacody, and oral sodium phosphate in preparation of patients for colonoscopy. | Internal | |||
| Hilsden | Understanding Canadians' preferences for a colorectal cancer screening program | CIHR | 2005 - 2008 |
$99,810 | |
| Hilsden | Societalcosts of colorectal cancer screening in Alberta |
AHFMR | 2005 - 2008 |
$129,755 |
CIHR: Canadian Institutes of Health Research
PDI: Phenomenome Discoveries Inc, Saskatoon, SK